Related Experiment Video

Updated: Jun 14, 2026

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
10:18

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on: July 7, 2023

Patented cancer vaccines: the promising leads

Luigi Aurisicchio1, Gennaro Ciliberto

  • 1Biogem IRGS, Dept of Molecular Oncology, via Camporeale 83031, Ariano Irpino (AV), Italy. luigi_aurisicchio@libero.it

Expert Opinion on Therapeutic Patents
|March 30, 2010
PubMed
Abstract

Insights

Therapeutic cancer vaccines show promise for long-term survival, with advances in modified peptide vaccines and novel technologies. These vaccines will likely complement, not replace, traditional cancer treatments.

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • Cancer remains a significant unmet medical need and leading cause of death globally.
  • Therapeutic cancer vaccines are anticipated to become a reality, driven by market demand and growing intellectual property.
  • Ongoing research explores novel avenues in cancer vaccine development.

Purpose of the Study:

  • To review and analyze recent intellectual property in therapeutic cancer vaccines.
  • To highlight significant advancements and emerging trends in cancer vaccine technology.
  • To assess the potential of new cancer vaccines in clinical settings.

Main Methods:

  • Evaluation of over 200 patents issued within the last four years.
  • Selection and commentary on relevant patents representing key innovations.
  • Analysis of advancements in vaccine platforms, antigens, and adjuvants.

Main Results:

  • Significant progress in modified peptide vaccines and engineered tumor-associated antigens.
  • Development of novel vaccination technologies and evaluation of new adjuvants.
  • Emerging tumor-associated and stromal antigens are in early clinical trials with promising outcomes.

Conclusions:

  • Cancer vaccines hold potential for long-term patient survival but are not standalone therapies.
  • Future cancer vaccines will likely be integrated with standard treatments and immunomodulators.
  • Despite limited current market products, the field shows considerable promise for future cancer care.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...